Lakewood
Lakewood
Lakewood, California, United States13 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease | Alzheimer disease, Dyskinesias, Neurobehavioral Manifestations, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Psychomotor Agitation, Psychomotor Disorders, Signs and Symptoms, brain disorder, central nervous system disorder, cognitive disorder, dementia, nervous system disorder, neurodegenerative disease, psychiatric disorder, tauopathy | Recruiting | Phase 2 | 2026-10-06 | NCT06808984 | |
| An Open-label, Single-arm Study of Prophylaxis for Datopotamab Deruxtecan (Dato-DXd) -Related Stomatitis in Eligible Patients With Metastatic or Inoperable Locally Recurrent Breast Cancer or Locally Advanced or Metastatic Epidermal Growth Factor Receptor-Mutated Non-small Cell Lung Cancer. | Stomatognathic Diseases, mouth disorder, stomatitis | Recruiting | Phase 4 | 2026-09-30 | NCT07357597 | |
| A Study of Tebapivat (AG-946) in Participants With Anemia Due to Lower-Risk Myelodysplastic Syndromes (LR-MDS) | Hemic and Lymphatic Diseases, anemia, bone marrow disorder, hematologic disorder, myelodysplastic syndrome | Active, not recruiting | Phase 2 | 2026-09-28 | NCT05490446 | |
| Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin | cardiovascular disorder, heart disorder, heart failure | Recruiting | Phase 3 | 2026-09-15 | NCT06677060 | |
| Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease | Chronic Disease, Chronic Kidney Diseases, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, chronic renal failure syndrome, diabetes mellitus, endocrine system disorder, glucose metabolism disease, kidney disorder, kidney failure, metabolic disease, type 2 diabetes mellitus, urinary system disorder | Active, not recruiting | Phase 3 | 2026-08-11 | NCT05099770 | |
| A Trial of Casdozokitug in Combination With Toripalimab Plus Bevacizumab in Participants With Unresectable and/or Locally Advanced or Metastatic Hepatocellular Carcinoma | Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasm | Active, not recruiting | Phase 2 | 2026-07-15 | NCT06679985 | |
| A Study of Dato-DXd With or Without Durvalumab Versus Investigator's Choice of Therapy in Patients With Stage I-III Triple-negative Breast Cancer Without Pathological Complete Response Following Neoadjuvant Therapy (TROPION-Breast03) | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Active, not recruiting | Phase 3 | 2026-06-15 | NCT05629585 | |
| A Dose Escalation Study of AV-380 in Cancer Patients With Cachexia | Body Weight, Body Weight Changes, Cachexia, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Thinness, Weight Loss | Recruiting | Phase 1 | 2026-01-08 | NCT05865535 | |
| Site and Mechanism(s) of Expiratory Airflow Limitation in COPD, Emphysema and Asthma-COPD Overlap | Chronic Disease, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, chronic obstructive pulmonary disease, lung disorder, obstructive lung disease, pulmonary emphysema, respiratory system disorder | Recruiting | Not stated | 2023-10-27 | NCT03263130 | |
| Detection of Unsuspected Small Airways Obstruction in Cystic Fibrosis | bronchial disorder, bronchiectasis, respiratory system disorder | Recruiting | Not stated | 2023-10-26 | NCT03839992 | |
| Mechanism(s) of Airflow Limitation During Exacerbation of Asthma | Hypersensitivity, Immediate, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Respiratory Hypersensitivity, asthma, bronchial disorder, immune system disorder, lung disorder, obstructive lung disease, respiratory system disorder | Recruiting | Phase 4 | 2023-10-26 | NCT01225913 | |
| Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma | Hypersensitivity, Immediate, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Respiratory Hypersensitivity, asthma, bronchial disorder, immune system disorder, lung disorder, obstructive lung disease, respiratory system disorder | Recruiting | Not stated | 2023-10-26 | NCT00576069 | |
| Congenital Muscle Disease Study of Patient and Family Reported Medical Information | Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Emery-Dreifuss muscular dystrophy, Eye Diseases, Hereditary, Malformations of Cortical Development, Group II, Muscular Disorders, Atrophic, Neurobehavioral Manifestations, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Thomsen and Becker disease, Wieacker-Wolff syndrome, X-linked disease, autosomal recessive limb-girdle muscular dystrophy type 2G, autosomal recessive limb-girdle muscular dystrophy type 2M, brain disorder, central nervous system disorder, central nervous system malformation, cerebral cortical dysplasia, cobblestone lissencephaly, congenital muscular dystrophy due to integrin alpha-7 deficiency, congenital myasthenic syndrome, epilepsy, eye disorder, hereditary disease, inherited neurodegenerative disorder, intellectual disability, limb-girdle muscular dystrophy, lissencephaly spectrum disorders, muscle tissue disorder, muscular dystrophy, muscular dystrophy-dystroglycanopathy, type A, musculoskeletal system disorder, myotonic syndrome, nervous system disorder, neurodegenerative disease, neurodevelopmental disorder, neuromuscular disease, neuromuscular junction disease, psychiatric disorder | Recruiting | Not stated | 2021-08-09 | NCT01403402 |